Pull to refresh
Logo
Daily Brief
Following
Why Sign Up
Yilai Shu

Yilai Shu

Principal Investigator, Eye and ENT Hospital of Fudan University

Appears in 1 story

Stories

Gene therapy restores hearing in deaf patients

New Capabilities

Led first successful human gene therapy trial for hearing loss

Children born profoundly deaf can now hear their parents' voices. A single injection of gene therapy into the inner ear has restored hearing in dozens of patients with genetic deafness, moving some forms of lifelong hearing loss from permanent disability into the treatable category. The effect is rapid—most patients recover hearing within weeks—and sustained over at least two years of follow-up.

Updated Jan 9